Format

Send to

Choose Destination
See comment in PubMed Commons below
Appl Radiat Isot. 1998 Apr;49(4):285-94.

Radionuclide development at BNL for nuclear medicine therapy.

Author information

1
Brookhaven National Laboratory, Medical Department, Upton, NY 11973-5000, USA.

Abstract

Radionuclides with medium energy beta emission and a several day half-life have often been viewed as attractive candidates for radioimmunotherapy. Among the most promising in this category are 47Sc, 67Cu, 153Sm, 188Re, and 199Au. The production of 67Cu, 153Sm, 199Au at BNL is summarized and the development of the latest candidate for this application, 47Sc, is described in detail. We also summarize the development of another important therapeutic radionuclide, 117mSn for bone pain palliation.

PMID:
9519438
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center